Healthcare communications firm Spok's Q3 revenue falls 2.9%, reaffirms 2025 guidance

Reuters
2025/10/30
Healthcare communications firm Spok's Q3 revenue falls 2.9%, reaffirms 2025 guidance

Overview

  • Spok Q3 2025 total revenue declines 2.9% yr/yr

  • Wireless ARPU rises 3% yr/yr, net churn improves by 20 bps

  • Company returns $6.4 mln in capital to stockholders in Q3 2025

Outlook

  • Spok reaffirms 2025 revenue guidance of $138.0 mln to $143.5 mln

  • Company expects 2025 adjusted EBITDA between $28.5 mln and $32.5 mln

  • Spok projects 2025 wireless revenue between $71.5 mln and $73.5 mln

Result Drivers

  • MANAGED SERVICES REVENUE - Growth in managed services revenue contributed to stable software revenue despite declines in other areas

  • WIRELESS ARPU - Wireless average revenue per unit increased by 3% year-over-year, supporting revenue stability

  • R&D INVESTMENT - Spok invested $9.1 mln in R&D to support future growth in its product platform

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Net Income

$3.20 mln

Q3 Adjusted EBITDA

$6.61 mln

Q3 Adjusted Operating Expenses

$28.48 mln

Q3 Operating Expenses

$29.51 mln

Q3 Software Revenue

$16.07 mln

Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the wireless telecommunications services peer group is "buy"

  • Wall Street's median 12-month price target for Spok Holdings Inc is $19.50, about 15.8% above its October 28 closing price of $16.41

  • The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 22 three months ago

Press Release: ID:nBw7j0d03a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10